1 1

FDA NDA 209988, FUROSCIX, SCPHARMACEUTICALS, 10/07/2022

FDA NDA 209988, FUROSCIX, SCPHARMACEUTICALS, 10/07/2022

$89.00 USD
$89.00 USD
Sale Sold out

Contents: Summary Basis of Approval (Approval Package) for NDA 209988 [Furoscix (furosemide injection)] approved on October 7, 2022.

NDA: 209988
Company: SCPHARMACEUTICALS
Drug Name: FUROSCIX
Active Ingredients: FUROSEMIDE
Strength: 80MG/10ML (8MG/ML)
Dosage Form/Route: SOLUTION;SUBCUTANEOUS
Action Date: 10/07/2022
Marketing Status: Prescription
Submission Classification: ORIG-1
Action Date: None

658 Pages
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome